[1]
World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases A comprehensive approach. Geneva: WHO 2007.
[4]
Pneumonia: The forgotten killer of children. Geneva, The United Nations Children’s Fund (UNICEF)/ World Health Organization (WHO) 2006.
[5]
Global Tuberculosis Report. Geneva: World Health Organization 2016.
[7]
World Health Organization World Health Statistics. France 2011.
[10]
GBD 2015 Mortality and Causes of Death Collaborators, Global, regional, and national life expectancy, allcause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015; 388: 1459-544.
[12]
Teng C, Leong K, Aljunid S, Cheah M. Antibiotic prescription in upper respiratory tract infections. Asia Pac Fam Med 2004; 3(12): 3845-57.
[13]
Ray O’Connor. Jane O’Doherty, Andrew O’Regan, Colum Dunne. Antibiotic use for acute respiratory tract infections (ARTI) in primary care. Irish J Med Sci 2018; 187: 969-86.
[16]
National Institute for Health and Clinical Excellence Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. Clinical Guideline 69 London: NICE 2008.
[18]
Truter I. A review of drug utilization studies and methodologies. Jordan J Pharm Sci 2010; 1(2): 91-104.
[20]
Thomas M, Paul AB. Upper respiratory tract infection. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing 2020; pp. 121-46.
[22]
Nandimath MK, Ahuja S. Drug prescribing pattern in upper respiratory tract infection in children aged 1-14 years. Int J Pharma Bio Sci 2012; 3(1): 299-308.
[23]
Khan IA, Shobha Rani RH, Subramanyam G. Efficacy and safety of azithromycin with various cephalosporins used in treatment of lower respiratory tract infection. Indian J Pharm Practic 2009; 1(2): 53-61.
[28]
Arroll B. Common cold BMJ Clin Evid 2008; 1-9.
[29]
Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments. United States, 1997. Vital Health Stat 1999; 13(143): 1-39.
[34]
Mary T. Caserta. Acute Laryngitis. In: Mandell D, Bennett JE, Eds.
Principles and Practice of Infectious Diseases. 2015; pp. 760-1.
[36]
Gupta G, Mahajan K. Acute Laryngitis 2020 01-9.
[40]
Scottish Intercollegiate Guidelines Network.SIGN Clinical Guideline 117: Management of Sore Throat and Indications for Tonsillectomy: A National Clinical Guideline. Edinburgh. 2010; pp. 47- 69.
[46]
Centre for Disease Control and Prevention. Summary health statistics for U.S. adults: National Health Interview Survey 2009; 411- 34
[48]
Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007; •••: 137-59.
[51]
Meherali S, Campbell A, Hartling L, Scott S. Understanding parents’ experiences and information needs on pediatric acute otitis media: a qualitative study. J Patient Exp 2019; 6(1): 345-61.
[52]
Protasova IN. Per’yanovaOV, Podgrushnaya TS. Acute otitis media in the children: etiology and the problems of antibacterial therapy. Vestn Otorinolaringol 2017; •••: 1-9.
[54]
Kathryn M, Blackwood A. Heather lB, James MC, Van H, Peter PP. Otitis media: Diagnosis and treatment. Am Fam Physician 2013; 88(7): 435-40.
[55]
University of Michigan Health System. Guidelines for clinical care: Otitis Media. 2012.
[56]
Becker LA, Hom J, Villasis-Keever M, et al. Beta2 agonists for acute bronchitis The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd. 2015.
[81]
Sobol SE, Schloss MD, Tewfik TL. Sinus, acute, medical treatment 2005 601-21.
[82]
Tse J, Cosep ML, Aminimanizani A, Gill MA. Community acquired pneumonia. California Pharmacist 2002-2003; (Winter): 54-65.
[84]
Community-acquired pneumonia, management, NDA, AVELOX 2016; 1-27
[85]
File TM Jr. Overview of community-acquired respiratory tract infectionsCommunity-Acquired Respiratory Infections: Antimicrobial Management. New York, NY: Marcel Dekker, Inc 2003; pp. 1-30.
[86]
Stephen B. Treating community-acquired bacterial respiratory tract infections. J Fam Pract 2005; 54(4): 357-64.
[88]
Udaykumarpadmaja. Medicinal pharmacology. 5th edition. new delhi: CBS publication and distributors Pvt Ltd 2014; pp. 462-97.
[91]
Gujar A, Tiwari P. Antimicrobial drug use in hospitalized children. CRIPS 2008; 9(1): 2-6.
[94]
VinutnaGogineni. BabjiMallela, Namburi Reshma, Kumari Raj. Drug utilization study in patients with acute respiratory tract infections at a tertiary care hospital in Bhimavaram. India Int J Adv Res Develop 2018; 3(9): 35-42.
[96]
GirmaMamo. AbebaTeshome. Evaluation of antibiotics use in the treatment of upper respiratory tract infection in Bedele district hospital. Southwest Ethiopia J Sci Innov Res 2017; 6(1): 38-43.
[103]
World Health Organization (WHO/ SEARO) The role of education in the rational use of medicines, SEARO Technical Publication Series No 45. New Delhi: Regional office for South East Asia 2006.
[105]
Dr Nirmal K. Ganguly Rationalizing antibiotic use to limit antibiotic resistance in India. National Institute of Immunology 2011; pp. 281-94.
[108]
Centers for Disease Control and Prevention Antibiotic Resistance Threats in the United States. Atlanta, GA: Centers for Disease Control and Prevention 2014.
[110]
Younis BB, Arshad R, Masood J, Khurshid S, Nazeer F, Tahira M. A Study of Unnecessary Use of Antibiotics at a Tertiary care hospital: Urgent need to implement antimicrobial stewardship programs. J Young Pharm 2015; 7(4): 127-35.
[114]
World Health Organization. Antimicrobial resistance 2016.